Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009
...on in the market, tempered by an increase in volume of certain products such as tramadol APAP and fluoxetine HCl, as well as the launch of risperidone odt
in June 2009.
Megace(R) ES: Net sales were $17.1 million for the three months ended June 27, 2009 compared to $13.5 million in th...
MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip
...herapy, radiotherapy and surgery. The NDA is supported by positive data from successfully completed pivotal bioequivalence studies against ondansetron odt
(orally disintegrating tablets), both with and without water. Pursuant to Prescription Drug User Fee Act (PDUFA) guidelines, the FDA is expected to re...
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
...otrigine) Orally Disintegrating Tablets. Lamictal odt
uses a novel drug-delivery formulation to provide...es. "Orally disintegrating tablets, like Lamictal odt
, offer an option for patients who have difficulty swallowing tablets."
was approved based on the demonstrated bioequival...
Par Pharmaceutical Reports First Quarter 2008 Results
2009 Potential Launches Methylphenidate ER 20, 30, and 40 Ritalin(R) Capsules mg LA Alprazolam odt
Tablets 0.25, 0.5, 1, Niravam(R) and 2 mg Amlodipine + 5/40 and 10/40 Lotrel(R) Benazepril Capsules ...
Orapred ODT Tastes Good
Survey Shows 89% of Patients Prefer Orapred ODT
ALPHARETTA, Ga., March 29, 2007 /PRNewswire/ -- Alliant
Pharmaceuticals announced today survey results showing that
children prefer Orapred ODT(TM) (Prednisolone sodium phosphate
orally disintegrating tablets) over liquid steroids.(1)